Instil Bio, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
BML Investment Partners, L.P. has disclosed a 9.5% beneficial ownership stake in Instil Bio, Inc. common stock.
NASDAQ
Vivo Capital entities have reported a 4.5% passive ownership stake in Instil Bio, Inc., holding 292,743 shares of common stock.
NASDAQ
SCHEDULE 13G/A: Boxer Capital Entities Report Reduced Stake in Instil Bio, Fall Below 5% Ownership Threshold
Boxer Capital Management LLC and Aaron I. Davis, along with affiliated entities, have reported ceasing to beneficially own more than 5% of Instil Bio, Inc.'s common stock, now holding 1.2% of the outstanding shares.
NASDAQ
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed an amended Schedule 13G, reporting a complete divestment of their beneficial ownership in Instil Bio, Inc.'s common stock, reducing their stake to 0.0%.
NASDAQ
SCHEDULE 13G/A: BML Investment Partners and Leonard Braden Michael Disclose Significant Stake in Instil Bio, Inc.
BML Investment Partners, L.P. and Leonard Braden Michael have jointly disclosed a beneficial ownership of 6.74% in Instil Bio, Inc.'s common stock as of December 31, 2024.